Kamada (KMDA) Change in Working Capital (2012 - 2026)
Kamada (KMDA) posted quarterly Change in Working Capital of -$12.1 million for Q1 2026, up 2.5% year-on-year from -$11.8 million in Q1 2025, and down 379.26% on a QoQ basis from $4.3 million in Q4 2025.
Kamada (KMDA) Change in Working Capital (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Change in Working Capital for 15 consecutive years, with -$12.1 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Working Capital rose 2.5% year-over-year to -$12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.5 million (down 217.0% YoY) and the FY2025 annual result came in at -$17.7 million, down 186.96% from the prior year.
- Change in Working Capital fell to -$12.1 million in Q1 2026 per KMDA's latest filing, from $4.3 million in the prior quarter.
- Over the last five years, Change in Working Capital for KMDA reached as high as $13.0 million in Q3 2024 and fell as low as -$12.4 million in Q1 2025.
- A 5-year average of -$295901.7 and a median of -$314.0 in 2022 frame the typical range for Change in Working Capital.
- The largest YoY upside for Change in Working Capital was 30558.29% in 2023 against a maximum downside of 2048944.59% in 2023.
- Year by year, Change in Working Capital stood at $4299.0 in 2022, then surged by 30558.29% to $1.3 million in 2023, then soared by 324.13% to $5.6 million in 2024, then retreated by 22.36% to $4.3 million in 2025, then sank by 379.26% to -$12.1 million in 2026.
- According to Business Quant data, Change in Working Capital over the past three periods registered -$12.1 million, $4.3 million, and -$1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -617.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | -12.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.12 Mn |
| Mar 31, 2026 | -12.12 Mn |
| Dec 31, 2025 | 4.34 Mn |
| Dec 31, 2025 | 4.34 Mn |
| Sep 30, 2025 | -1.55 Mn |
| Sep 30, 2025 | -1.55 Mn |
| Jun 30, 2025 | -3.22 Mn |
| Jun 30, 2025 | -3.22 Mn |
| Mar 31, 2025 | -12.43 Mn |
| Mar 31, 2025 | -12.43 Mn |
| Dec 31, 2024 | 5.59 Mn |
| Dec 31, 2024 | 5.59 Mn |
| Sep 30, 2024 | 13.01 Mn |
| Sep 30, 2024 | 13.01 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | -6.62 Mn |
| Mar 31, 2024 | -6.62 Mn |
| Dec 31, 2023 | 1.32 Mn |
| Dec 31, 2023 | 1.32 Mn |